Nine Chapters Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Nine Chapters Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-16,300	Closed	-$644K	–	39
2015 Q3	$644K	Buy	+16,300	New	+$927K	0.06%	487
2015 Q2	–	Sell	-5,800	Closed	-$363K	–	947
2015 Q1	$363K	Sell	5,800 -9,800	-63%	-$596K	0.03%	675
2014 Q4	$880K	Buy	+15,600	New	+$688K	0.08%	369

Other funds holding ANIP

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Nine Chapters Capital Management's ANIP Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2015, closing a stake of 16,300 shares — an estimated $644K sold.

Nine Chapters Capital Management first reported a position in ANIP in Q4 2014 and held it in 3 quarters. The position peaked at $880K in Q4 2014. 123 funds tracked by Wall St. Rank hold ANIP as of Q4 2015.

Nine Chapters Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 16,300 ANI Pharmaceuticals shares in Q4 2015, an estimated $644K.
Nine Chapters Capital Management first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 3 quarters.
Nine Chapters Capital Management's ANI Pharmaceuticals position peaked at $880K in Q4 2014.
123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.